Toll Free: 1-888-928-9744
Published: May, 2014 | Pages:
33 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Northwest Biotherapeutics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Northwest Biotherapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Northwest Biotherapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Northwest Biotherapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Northwest Biotherapeutics, Inc.'s pipeline products Reasons to buy - Evaluate Northwest Biotherapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Northwest Biotherapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Northwest Biotherapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Northwest Biotherapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Northwest Biotherapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Northwest Biotherapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Northwest Biotherapeutics, Inc. Snapshot 4 Northwest Biotherapeutics, Inc. Overview 4 Key Information 4 Key Facts 4 Northwest Biotherapeutics, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Northwest Biotherapeutics, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Northwest Biotherapeutics, Inc. - Pipeline Products Glance 9 Northwest Biotherapeutics, Inc. - Late Stage Pipeline Products 9 Phase III Products/Combination Treatment Modalities 9 Northwest Biotherapeutics, Inc. - Clinical Stage Pipeline Products 10 Phase I Products/Combination Treatment Modalities 10 Northwest Biotherapeutics, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Northwest Biotherapeutics, Inc. - Drug Profiles 12 DCVax-L Vaccine 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 DCVax-Prostate 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 DCVax-Direct 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CXCR4 Antibody 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Northwest Biotherapeutics, Inc. - Pipeline Analysis 17 Northwest Biotherapeutics, Inc. - Pipeline Products by Target 17 Northwest Biotherapeutics, Inc. - Pipeline Products by Route of Administration 18 Northwest Biotherapeutics, Inc. - Pipeline Products by Molecule Type 19 Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action 20 Northwest Biotherapeutics, Inc. - Recent Pipeline Updates 21 Northwest Biotherapeutics, Inc. - Company Statement 28 Northwest Biotherapeutics, Inc. - Locations And Subsidiaries 31 Head Office 31 Other Locations & Subsidiaries 31 Appendix 32 Methodology 32 Coverage 32 Secondary Research 32 Primary Research 32 Expert Panel Validation 32 Contact Us 33 Disclaimer 33
List of Tables Northwest Biotherapeutics, Inc., Key Information 4 Northwest Biotherapeutics, Inc., Key Facts 4 Northwest Biotherapeutics, Inc. - Pipeline by Indication, 2014 6 Northwest Biotherapeutics, Inc. - Pipeline by Stage of Development, 2014 7 Northwest Biotherapeutics, Inc. - Monotherapy Products in Pipeline, 2014 8 Northwest Biotherapeutics, Inc. - Phase III, 2014 9 Northwest Biotherapeutics, Inc. - Phase I, 2014 10 Northwest Biotherapeutics, Inc. - Preclinical, 2014 11 Northwest Biotherapeutics, Inc. - Pipeline by Target, 2014 17 Northwest Biotherapeutics, Inc. - Pipeline by Route of Administration, 2014 18 Northwest Biotherapeutics, Inc. - Pipeline by Molecule Type, 2014 19 Northwest Biotherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2014 20 Northwest Biotherapeutics, Inc. - Recent Pipeline Updates, 2014 21 Northwest Biotherapeutics, Inc., Subsidiaries 31
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.